Construction of thyroid cancer classification and iodine metabolism related diagnostic model using thyroid differentiation score and bioinformation
Authors:
Open Access
- 6 September 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (36) , e39464
Abstract
To more accurately diagnose and treat patients with different subtypes of thyroid cancer, we constructed a diagnostic model related to the iodine metabolism of THCA subtypes. THCA expression profiles, corresponding clinicopathological information, and single-cell RNA-seq were downloaded from TCGA and GEO databases. Genes related to thyroid differentiation score were obtained by GSVA. Through logistic analyses, the diagnostic model was finally constructed. DCA curve, ROC curve, machine learning, and K-M analysis were used to verify the accuracy of the model. qRT-PCR was used to verify the expression of hub genes in vitro. There were 104 crossover genes between different TDS and THCA subtypes. Finally, 5 genes (ABAT, CHEK1, GPX3, NME5, and PRKCQ) that could independently predict the TDS subpopulation were obtained, and a diagnostic model was constructed. ROC, DCA, and RCS curves exhibited that the model has accurate prediction ability. K-M and subgroup analysis results showed that low model scores were strongly associated with poor PFI in THCA patients. The model score was significantly negatively correlated with T cell follicular helper. In addition, the diagnostic model was significantly negatively correlated with immune scores. Finally, the results of qRT-PCR corresponded with bioinformatics results. This diagnostic model has good diagnostic and prognostic value for THCA patients, and can be used as an independent prognostic indicator for THCA patients.Keywords
This publication has 47 references indexed in Scilit:
- MiR-146b-5p regulates the scavenging effect of GPx-3 on peroxide in papillary thyroid cancer cellsHeliyon, 2023
- Corrigendum to “ABAT targeted by miR-183-5p regulates cell functions in liver cancer” [Int. J. Biochem. Cell Biol. 141 (2021) 106116]The International Journal of Biochemistry & Cell Biology, 2022
- Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkersESMO Open, 2021
- Pembrolizumab for anaplastic thyroid cancer: a case studyCancer Immunology, Immunotherapy, 2019
- Association of Papillary Thyroid Carcinoma with GIST—a Case SeriesIndian Journal of Surgical Oncology, 2019
- T Follicular Helper Cell Biology: A Decade of Discovery and DiseasesImmunity, 2019
- Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancerMolecular Oncology, 2014
- Integrated Genomic Characterization of Papillary Thyroid CarcinomaCell, 2014
- Genetics and epigenetics of sporadic thyroid cancerMolecular and Cellular Endocrinology, 2014
- Dedifferentiated thyroid cancer: A therapeutic challengeBiomedicine & Pharmacotherapy, 2008